Skip to content

Biofrontera AG Sustainability Reports

Biofrontera AG is a biopharmaceutical company specializing in the development and commercialization of dermatological drugs and medical cosmetics, with a primary focus on photodynamic therapy products for skin diseases.

Sector: Manufacturing

Country: Germany

Exchange: Deutsche Börse (Xetra)

ISIN: DE000A4BGGM7

25 reports from 2013 to 2025